These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9753848)

  • 21. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 24. [Implantable automatic defibrillator after MADIT and EMIAT].
    Farré J
    Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
    [No Abstract]   [Full Text] [Related]  

  • 25. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death.
    Heidenreich PA; Keeffe B; McDonald KM; Hlatky MA
    Am Heart J; 2002 Sep; 144(3):422-30. PubMed ID: 12228778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Malik M; Camm AJ
    Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398
    [No Abstract]   [Full Text] [Related]  

  • 27. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 28. The SWORD of Damocles.
    Sanderson J
    Lancet; 1996 Jul; 348(9019):2-3. PubMed ID: 8691925
    [No Abstract]   [Full Text] [Related]  

  • 29. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 30. AVID necessity.
    Epstein AE
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1773-5. PubMed ID: 7692406
    [No Abstract]   [Full Text] [Related]  

  • 31. Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Böcker D; Block M; Borggrefe M; Breithardt G
    Eur Heart J; 1997 Jan; 18(1):26-30. PubMed ID: 9049512
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlling cardiac arrhythmias: an overview with a historical perspective.
    Singh BN
    Am J Cardiol; 1997 Oct; 80(8A):4G-15G. PubMed ID: 9354407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
    Bestetti R; Cardinalli-Neto A
    Europace; 2009 Apr; 11(4):537. PubMed ID: 19279026
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
    Tiroke A; Ganeeva ON
    Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ventricular arrhythmias in heart failure: drugs or devices.
    Gambhir DS
    Indian Heart J; 1998; 50(5):507-10. PubMed ID: 10052273
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.